SEC Tracker
Get the app

Edwards Lifesciences EW

Daniel J. Lippis reports insider trading

Daniel J. Lippis, insider filing for EW

Form
4
Filed
Importance
Routine
  1. Daniel J. Lippis sold 619 shares on Oct 8, 2026
  2. Daniel J. Lippis bought 619 shares on Oct 8, 2026
  3. Insider's ownership dropped to 40,033.91 shares

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Edwards Lifesciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3842 and related industry codes: the same peer list as the financial tables.

  1. Resmed RMD public float $34.9B, Dec 31, 2025
  2. Dexcom DXCM public float $34.2B, Jun 30, 2025
  3. GE HealthCare Technologies GEHC public float $34.0B, Jun 30, 2025
  4. Becton Dickinson BDX public float $65.5B, Mar 31, 2025, over 18 months old
  5. 3M MMM public float $81.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.